Federal Blood Regulations come into force
23 October 2013
These documents are available on the Canada Gazette website at http://www.gazette.gc.ca/index-eng.html and from the Health Canada website at http://www.hc-sc.gc.ca/dhp-mps/brgtherap/legislation/gazette2/index-eng.php.
The Blood Regulations contain safety requirements with respect to blood for transfusion or for further manufacture and apply to all persons or establishments who perform any of the following activities related to blood: processing (donor suitability assessment, collection, testing and blood component preparation); transforming (washing, pooling and irradiating blood intended for transfusion); labelling; storing; record keeping; importing (for transfusion); distributing; and error, accident and adverse reaction investigation and reporting.
OFC releases 2013 assessment
23 September 2013
The OFC deemed CMLTO's Assessment of Qualifications as a commendable practice and has not made any recommendations for this assessment period.
Read the report (PDF) now.
Ontario Cervical Screening Program (OCSP) update
23 September 2013
Read about the changes and their impact on laboratories here.
Update: Ontario Cervical Screening Program (OCSP)
23 September 2013
Cancer Care Ontario's Dr. Linda Rabeneck, Vice-President, Prevention and Cancer Control; Dr. Joan Murphy, Clinical Lead, Ontario Cervical Screening Program; and Dr. Suzanne Strasberg, Provincial Lead, Primary Care, issued the following update to practitioners on September 20, 2013.
We are pleased to share with you an important update about the enhancement of the Ontario Cervical Screening Program (OCSP).
As you are aware, the cervical screening program enhancement is underway, beginning with letters in August to women who have recently had a Pap test. These letters let women know about our program, informed them of our privacy guidelines and gave them the choice to opt out of receiving correspondence from Cancer Care Ontario (CCO).
Starting September 19th, CCO will begin sending result letters to women age 21 and over who have recently had a Pap test (but only to those who did not opt out of the correspondence program).
In the coming months, CCO will also send reminder letters to women aged 21 to 69 who were screened 35 months ago to let them know they are due for re-screening. Invitation letters will then be sent to women aged 30 to 69 years who were not screened within the prior 36 months. These letters will help women stay up-to-date with cervical cancer screening and encourage them to talk to their healthcare provider about screening.
In the year ahead, we will also be expanding our letters to the public for breast and colorectal cancer screening. In anticipation of successful program growth, we recognize that your laboratory may experience higher volumes associated with increased screening in Ontario.
We will continue to provide you with updates because we believe it is important that our key partners remain informed about each phase of this work so they can adequately prepare for changes that may affect them.
If you have any questions, please call us toll-free at 1-866-662-9233 or e-mail us at primarycare@cancercare.on.ca.
For information on cervical screening guidelines or our easy-to-use clinical resources, including our newly developed mobile apps, please visit www.cancercare.on.ca/pcresources.
NW LHIN looking for practicing health professionals
06 September 2013
The HPAC is composed of members from a range of health services professions and has the responsibility of providing advice to the LHIN on how to achieve patient-centred health care. It is a volunteer committee and members will not be compensated for their role on the committee.
Click here to learn more.
Request a CMLTO speaker
27 August 2013
CMLTO is already booked to make several presentations to medical laboratory staff across Ontario this fall.
To request a presentation by CMLTO at your organization, please email member_relations@cmlto.com
Cancer Care Ontario expands OCSP
16 August 2013
TPH Surveillance alert
24 July 2013
Addition of SCID to Newborn Screening Test
24 July 2013
These changes were made to allow: the addition of Severe Combined Immune Deficiency (SCID) to the Newborn Screening Test; midwives to order SCID; and SCID to be an insured service.
Read the PDF of memo here for full details.
New PPLP module: Abuse prevention
28 June 2013
The latest module is Abuse prevention (PDF), which examines and identifies:
- forms of abuse
- zero tolerance position.
- those at risk for abuse.
- environments and areas of practice where abuse and/or boundary risks may occur or exist.
- appropriate professional boundaries.
- risks associated with crossing boundaries.
- reporting obligations
- effective abuse prevention communication skills.